Remove 2019 Remove Insurance Remove Labelling
article thumbnail

Can you take glimepiride and metformin together?

The Checkup by Singlecare

It is FDA approved to treat Type 2 diabetes along with diet and exercise in adults and children 10 years and older, but it also has various off-label uses. On top of that, metformin is sometimes prescribed off-label to treat Type 1 diabetes , while glimepiride is only suitable for Type 2. and Miriam B. Morkos , Pharm.D. of Marshall B.

article thumbnail

Pharmacists Have a Crucial Role Helping Patients With ATTR-CM Navigate Treatment With Tafamidis

Pharmacy Times

1,2 Tafamidis in the Treatment of ATTR-CM Initially approved in 2019 3 , tafamidis (Vyndamax; Pfizer) is a selective transthyretin (TTR) kinetic stabilizer that binds to thyroxine-binding sites on TTR tetramers, which prevents dissociation into monomers, or the breakdown into amyloid deposits that damage the heart in ATTR-CM. May 6, 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fentanyl facts and statistics

The Checkup by Singlecare

It can be prescribed off-label for certain types of pain, especially severe acute pain or pain caused by cancer. Fentanyl may also be prescribed off-label, meaning for a purpose other than what the Food and Drug Administration (FDA) approved it for. As of Sept. DEA, 2024) Another report found that U.S. For example: A 2021 study of U.S.

article thumbnail

Mifepristone Reduces HbA1c in Patients With T2D, Hypercortisolism | ADA 2025

Drug Topics

The study also showed the therapy’s safety profile was consistent with its current label. Related Content GLP-1 Use Increased Significantly Among Pediatric Patients With T2D in Past 5 Years | ADA 2025 Killian Meara June 25th 2025 Article From 2019 to 2024, GLP-1 prescriptions among pediatric patients with type 2 diabetes increased from 12.3%

article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

1 Researchers conducted a retrospective, observational analysis using data from January 2019 to March 2024. of YA with obesity were prescribed OMs—predominantly GLP-1s approved for adults but used off label for younger people. It also included individuals with a BMI greater than or equal to the 95th percentile of age and gender.

article thumbnail

J&J eyes prostate cancer label expansion for Akeega

Pharmaceutical Technology

The hormone therapy, approved in 2019, is forecast to see annual sales of $5.3bn by 2031. Robert Barrie July 7, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The application comes hot on the heels of positive data for Akeega unveiled at this year’s American Society of Clinical Oncology (ASCO) conference.

article thumbnail

Sarepta and Roche halt DMD gene therapy’s use after second death  

Pharmaceutical Technology

By GlobalData Learn more about Strategic Intelligence Corwin added that Elevidys’s label will likely be updated to reflect the risk of ALF. Sarepta Therapeutics, who developed the therapy, holds US rights to the drug, while Roche gained rights to other global territories through a 2019 agreement.